Our results reveal a novel regulatory pathway linking MeCP2, an epigenetic transcriptional regulator and an ASD-Rett syndrome causative gene, with the interactome of the schizophrenia susceptibility gene product dysbindin. This evidence concerns the gene DTNBP1 and schizophrenia.